Ogier’s Cayman Islands team has advised ARYA Sciences Acquisition Corp. on its initial public offering of 14,375,000 units at $10.00 per unit, which included the exercise in full of the underwriters’ over-allotment option to purchase up to 1,875,000 units. The sponsor of the IPO is ARYA Sciences Holdings, which is controlled by the principals of Perceptive Advisors, LLC. The units are listed on The Nasdaq Capital Market.
ARYA Sciences Acquisition Corp. is a newly organized blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, focusing on the healthcare or healthcare related industries.
Ogier’s team was led by partner Angus Davison, and included partner Bradley Kruger, senior associates Cynthia Anandajayasekeram and Tommy Tuohy, and associate Michael Robinson.
Angus said: “We are delighted to have been able to assist ARYA with the successful closing of its initial public offering, working alongside Kirkland & Ellis LLP as US counsel to the issuer. This transaction continues a busy year for Ogier’s global capital markets practice.”
Kirkland & Ellis LLP acted as US counsel to the issuer while Skadden, Arps, Slate, Meagher & Flom LLP advised the underwriters. Jefferies LLC acted as the sole book-running manager and Chardan acted as the lead manager for the offering.
